Inclusion Criteria:

- Has given written informed consent before any trial-related activity is performed.

- Has prostate cancer, and is in need of this type of treatment.

Exclusion Criteria:

- Has had previous or is currently under hormonal treatment of prostate cancer.

- Is considered to be candidate for radical prostatectomy or radiotherapy.

- Has a history of severe uncontrolled asthma and/or other severe allergic reactions.

- Has hypersensitivity towards any component of degarelix.

- Has had cancer within the last five years except prostate cancer and some types of
skin cancer.

- Has a severe disorder (other than prostate cancer) including but not limited to
liver, biliary, renal, haematological, gastrointestinal, endocrine, cardiac,
neurological, or psychiatric disease, and alcohol or drug abuse or any other
condition, as judged by the investigator.